Marieke C. Barnhoorn

Leiden, ZH, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Therapeutic potential of Janus kinase inhibitors for the management of fibrosis in inflammatory bowel disease.

Therapeutic potential of Janus kinase inhibitors for the management of fibrosis in inflammatory bowel disease.

Journal: Journal of Crohn's & colitis

Published: May 24, 2025

Stromal Cell Subsets Show Model-Dependent Changes in Experimental Colitis and Affect Epithelial Tissue Repair and Immune Cell Activation.

Stromal Cell Subsets Show Model-Dependent Changes in Experimental Colitis and Affect Epithelial Tissue Repair and Immune Cell Activation.

Journal: Inflammatory bowel diseases

Published: April 04, 2024

Activated HLA-DR+CD38+ Effector Th1/17 Cells Distinguish Crohn's Disease-associated Perianal Fistulas from Cryptoglandular Fistulas.

Activated HLA-DR+CD38+ Effector Th1/17 Cells Distinguish Crohn's Disease-associated Perianal Fistulas from Cryptoglandular Fistulas.

Journal: Inflammatory bowel diseases

Published: October 05, 2023

Local administration of mesenchymal stromal cells is safe and modulates the immune compartment in ulcerative proctitis.

Local administration of mesenchymal stromal cells is safe and modulates the immune compartment in ulcerative proctitis.

Journal: JCI insight

Published: November 22, 2022

Crohn's Disease-Associated and Cryptoglandular Fistulas: Differences and Similarities.

Crohn's Disease-Associated and Cryptoglandular Fistulas: Differences and Similarities.

Journal: Journal of clinical medicine

Published: October 20, 2022

Fecal Microbiota Transplantation for Immune Checkpoint Inhibitor-Induced Colitis Is Safe and Contributes to Recovery: Two Case Reports.

Fecal Microbiota Transplantation for Immune Checkpoint Inhibitor-Induced Colitis Is Safe and Contributes to Recovery: Two Case Reports.

Journal: Journal of immunotherapy (Hagerstown, Md. : 1997)

Published: September 09, 2022

Increased stromal PFKFB3-mediated glycolysis in inflammatory bowel disease contributes to intestinal inflammation.

Increased stromal PFKFB3-mediated glycolysis in inflammatory bowel disease contributes to intestinal inflammation.

Journal: Frontiers in immunology

Published: June 10, 2022

Cytokine Mixtures Mimicking the Local Milieu in Patients with Inflammatory Bowel Disease Impact Phenotype and Function of Mesenchymal Stromal Cells.

Cytokine Mixtures Mimicking the Local Milieu in Patients with Inflammatory Bowel Disease Impact Phenotype and Function of Mesenchymal Stromal Cells.

Journal: Stem cells translational medicine

Published: December 27, 2021

Azathioprine-induced Myelotoxicity After Switching Mesalazine Compound.

Azathioprine-induced Myelotoxicity After Switching Mesalazine Compound.

Journal: Inflammatory bowel diseases

Published: May 17, 2021

Contribution of CD3+CD8- and CD3+CD8+ T Cells to TNF-α Overexpression in Crohn Disease-Associated Perianal Fistulas and Induction of Epithelial-Mesenchymal Transition in HT-29 Cells.

Contribution of CD3+CD8- and CD3+CD8+ T Cells to TNF-α Overexpression in Crohn Disease-Associated Perianal Fistulas and Induction of Epithelial-Mesenchymal Transition in HT-29 Cells.

Journal: Inflammatory bowel diseases

Published: March 19, 2020

Stromal Cells in the Pathogenesis of Inflammatory Bowel Disease.

Stromal Cells in the Pathogenesis of Inflammatory Bowel Disease.

Journal: Journal of Crohn's & colitis

Published: March 12, 2020

Targeting Endoglin-Expressing Regulatory T Cells in the Tumor Microenvironment Enhances the Effect of PD1 Checkpoint Inhibitor Immunotherapy.

Targeting Endoglin-Expressing Regulatory T Cells in the Tumor Microenvironment Enhances the Effect of PD1 Checkpoint Inhibitor Immunotherapy.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: September 13, 2019

Showing 1-12 of 19

Last Updated: 09/26/2026